EX-23.1 4 mltx_ex231consentofindepen.htm EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-267673) and on Form S-3 (No. 333-274286 and 333-262643) of MoonLake Immunotherapeutics of our report dated February 26, 2025, relating to the consolidated financial statements and the effectiveness of internal control over financial reporting of MoonLake Immunotherapeutics, appearing in this Annual Report on Form 10-K of MoonLake Immunotherapeutics for the year ended December 31, 2024.

/s/ BAKER TILLY US, LLP
San Jose, CA
February 26, 2025